- Home
- / Ocumension Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ocumension Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.8
2024-10-29
Market Capitalization
$4.6 B
2024-10-29
Revenue
¥804.4 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 190.0K | 13.1M | 56.1M | 159.0M | 246.4M | 417.3M | 804.4M | |
| Cost of goods sold | 10.0K | 1.7M | 5.3M | 15.6M | 44.5M | 103.6M | 299.7M | |
| Gross profit | 180.0K | 16.4M | 51.5M | 150.8M | 203.2M | 338.2M | 508.7M | |
| Gross profit margin, % | 94.7% | 125.2% | 91.8% | 94.9% | 82.5% | 81.0% | 63.2% | |
| Operating expense total | 49.4M | 157.9M | 501.3M | 423.0M | 558.2M | 550.8M | 537.7M | 527.1M |
| Depreciation and amortization | 64.0K | 1.2M | 4.7M | 13.9M | 40.5M | 57.5M | 88.6M | 143.7M |
| EBITDA | (49.4M) | (157.7M) | (484.9M) | (384.8M) | (407.4M) | (347.6M) | (199.5M) | (18.4M) |
| EBITDA margin, % | -83021.1% | -3702.9% | -685.4% | -256.3% | -141.1% | -47.8% | -2.3% | |
| EBIT | (49.4M) | (158.9M) | (489.6M) | (298.1M) | (451.7M) | (405.2M) | (288.9M) | (162.1M) |
| EBIT margin, % | -83656.8% | -3738.4% | -530.9% | -284.1% | -164.5% | -69.2% | -20.2% | |
| Interest income | 25.0K | 3.9M | 14.3M | 26.9M | 28.2M | 21.9M | 22.2M | 6.4M |
| Interest expense | 5.0K | 63.0K | 59.0K | 567.0K | 1.8M | 1.3M | 2.2M | 2.4M |
| Pre tax profit | (209.4M) | (1.3B) | (2.3B) | (260.0M) | (402.2M) | (379.5M) | (267.3M) | (158.5M) |
| Income tax expense | 414.0K | 307.0K | 1.0M | 350.0K | ||||
| Net Income | (209.4M) | (1.3B) | (2.3B) | (260.0M) | (402.6M) | (379.8M) | (268.3M) | (158.8M) |